BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 10719695)

  • 1. Endoscopic scoring of late rectal mucosal damage after conformal radiotherapy for prostatic carcinoma.
    Wachter S; Gerstner N; Goldner G; Pötzi R; Wambersie A; Pötter R
    Radiother Oncol; 2000 Jan; 54(1):11-9. PubMed ID: 10719695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity: results of a prospective multicenter study of 166 patients.
    Goldner G; Tomicek B; Becker G; Geinitz H; Wachter S; Zimmermann F; Wachter-Gerstner N; Reibenwein J; Glocker S; Bamberg M; Feldmann H; Pötzi R; Molls M; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):78-83. PubMed ID: 17189064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healing of late endoscopic changes in the rectum between 12 and 65 months after external beam radiotherapy.
    Goldner G; Pötter R; Kranz A; Bluhm A; Dörr W
    Strahlenther Onkol; 2011 Mar; 187(3):202-5. PubMed ID: 21347635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced late rectal mucosal changes after prostate three-dimensional conformal radiotherapy with endorectal balloon as observed in repeated endoscopy.
    van Lin EN; Kristinsson J; Philippens ME; de Jong DJ; van der Vight LP; Kaanders JH; Leer JW; Visser AG
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):799-811. PubMed ID: 17161552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.
    Boersma LJ; van den Brink M; Bruce AM; Shouman T; Gras L; te Velde A; Lebesque JV
    Int J Radiat Oncol Biol Phys; 1998 Apr; 41(1):83-92. PubMed ID: 9588921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor and its correlation with clinical symptoms and endoscopic findings in patients with chronic radiation proctitis.
    Trzcinski R; Dziki A; Brys M; Moszynska-Zielinska M; Chalubinska-Fendler J; Mik M; Kujawski R; Dziki L
    Colorectal Dis; 2018 Apr; 20(4):321-330. PubMed ID: 28963746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer.
    Ippolito E; Guido A; Macchia G; Deodato F; Giaccherini L; Farioli A; Arcelli A; Cuicchi D; Frazzoni L; Cilla S; Buwenge M; Mantini G; Alitto AR; Nuzzo M; Valentini V; Ingrosso M; Morganti AG; Fuccio L
    In Vivo; 2017; 31(5):961-966. PubMed ID: 28882966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer.
    Campostrini F; Remo A; Astati L; Zorzi M; Capodaglio G; Buffoli A; Moretti G; Della Monica B; Zanella C; Verlato G
    Strahlenther Onkol; 2020 Jul; 196(7):617-627. PubMed ID: 32166451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-D conformal radiotherapy of localized prostate cancer: a subgroup analysis of rectoscopic findings prior to radiotherapy and acute/late rectal side effects.
    Goldner G; Zimmermann F; Feldmann H; Glocker S; Wachter-Gerstner N; Geinitz H; Becker G; Pötzi R; Wambersie A; Bamberg M; Molls M; Wachter S; Pötter R
    Radiother Oncol; 2006 Jan; 78(1):36-40. PubMed ID: 16271410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors.
    Wachter S; Gerstner N; Goldner G; Pötzi R; Wambersie A; Pötter R
    Radiother Oncol; 2001 Apr; 59(1):65-70. PubMed ID: 11295208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous improvement in late rectal mucosal changes after radiotherapy for prostate cancer.
    O'Brien PC; Hamilton CS; Denham JW; Gourlay R; Franklin CI
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):75-80. PubMed ID: 14697423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amifostine as radioprotective agent for the rectal mucosa during irradiation of pelvic tumors. A phase II randomized study using various toxicity scales and rectosigmoidoscopy.
    Kouvaris J; Kouloulias V; Malas E; Antypas C; Kokakis J; Michopoulos S; Matsopoulos G; Vlahos L
    Strahlenther Onkol; 2003 Mar; 179(3):167-74. PubMed ID: 12627259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
    Jackson A; Skwarchuk MW; Zelefsky MJ; Cowen DM; Venkatraman ES; Levegrun S; Burman CM; Kutcher GJ; Fuks Z; Liebel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2001 Mar; 49(3):685-98. PubMed ID: 11172950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
    Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response.
    Skwarchuk MW; Jackson A; Zelefsky MJ; Venkatraman ES; Cowen DM; Levegrün S; Burman CM; Fuks Z; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):103-13. PubMed ID: 10758311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Grading-system-dependent volume effects for late radiation-induced rectal toxicity after curative radiotherapy for prostate cancer.
    van der Laan HP; van den Bergh A; Schilstra C; Vlasman R; Meertens H; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1138-45. PubMed ID: 17931794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.
    Hanlon AL; Schultheiss TE; Hunt MA; Movsas B; Peter RS; Hanks GE
    Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):59-63. PubMed ID: 9212005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy.
    Ippolito E; Massaccesi M; Digesù C; Deodato F; Macchia G; Pirozzi GA; Cilla S; Cuscunà D; Di Lallo A; Mattiucci GC; Mantini G; Pacelli F; Valentini V; Cellini N; Ingrosso M; Morganti AG
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e191-5. PubMed ID: 22361084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy).
    Cozzarini C; Fiorino C; Ceresoli GL; Cattaneo GM; Bolognesi A; Calandrino R; Villa E
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):688-94. PubMed ID: 12573756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
    Peeters ST; Lebesque JV; Heemsbergen WD; van Putten WL; Slot A; Dielwart MF; Koper PC
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1151-61. PubMed ID: 16414208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.